PMID- 23679332 OWN - NLM STAT- MEDLINE DCOM- 20140107 LR - 20190606 IS - 2476-762X (Electronic) IS - 1513-7368 (Linking) VI - 14 IP - 3 DP - 2013 TI - Evidence for U.S. Preventive Services Task Force (USPSTF) recommendations against routine mammography for females between 40-49 years of age. PG - 2137-9 AB - Breast cancer is the most common cancer among females, worldwide, accounting for 22.9% of all cancers (excluding non-melanoma skin cancer) in women. Mammography is a sensitive (77-95%) and specific (94-97%) screening method for breast cancer. Previously, females between the 40-50 years old were recommended to have mammograms every one to two years. However, based on current evidence, in 2009, USPSTF recommended that the decision to start regular, biennial screening mammography for females younger than 50 years should be an individual decision and take patient context into account, including patient values regarding specific benefits and harms. This decision was based on findings regarding radiation exposure, false-positive and false-negative rates, over-diagnosis, and pain and psychological responses. The goal of this paper is to focus on evidence for updating the U.S. Preventive Services Task Force (USPSTF) recommendation against routine mammography for females between 40-49 years of age. FAU - Karimi, Parisa AU - Karimi P AD - Johns Hopkins University Bloomberg School of Public Health, Baltimore, USA. pkarimi@jhsph.edu FAU - Shahrokni, Armin AU - Shahrokni A FAU - Moradi, Sedighe AU - Moradi S LA - eng PT - Journal Article PL - Thailand TA - Asian Pac J Cancer Prev JT - Asian Pacific journal of cancer prevention : APJCP JID - 101130625 SB - IM MH - Adult MH - Advisory Committees/*standards MH - Age Factors MH - Breast Neoplasms/diagnosis/*prevention & control/psychology MH - Early Detection of Cancer MH - *Evidence-Based Medicine MH - Female MH - Humans MH - Mammography/*standards MH - Mass Screening/*standards MH - Middle Aged MH - Practice Guidelines as Topic/*standards MH - Preventive Health Services/*standards MH - Prognosis EDAT- 2013/05/18 06:00 MHDA- 2014/01/08 06:00 CRDT- 2013/05/18 06:00 PHST- 2013/05/18 06:00 [entrez] PHST- 2013/05/18 06:00 [pubmed] PHST- 2014/01/08 06:00 [medline] AID - 10.7314/apjcp.2013.14.3.2137 [doi] PST - ppublish SO - Asian Pac J Cancer Prev. 2013;14(3):2137-9. doi: 10.7314/apjcp.2013.14.3.2137.